Literature DB >> 17164832

Acute kidney injury following proton pump inhibitor therapy.

U C Brewster1, M A Perazella.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17164832     DOI： 10.1038/sj.ki.5002038

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  8 in total

Review 1.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

2.  Acute interstitial nephritis with membranous nephropathy in bucillamine-treated rheumatoid arthritis.

Authors:  Naoki Takamatsu; Hideki Takizawa; Hirohito Sugawara; Yayoi Ogawa
Journal:  CEN Case Rep       Date:  2015-12-08

Review 3.  PPIs and kidney disease: from AIN to CKD.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  J Nephrol       Date:  2016-04-12       Impact factor: 3.902

Review 4.  Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced Nephrotoxicity.

Authors:  Xiao Wei; Jun Yu; Zhengkun Xu; Chun Wang; Yonggui Wu
Journal:  Drug Saf       Date:  2022-06-01       Impact factor: 5.228

5.  Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.

Authors:  Pradeep Arora; Anu Gupta; Mojgan Golzy; Nilang Patel; Randolph L Carter; Kabir Jalal; James W Lohr
Journal:  BMC Nephrol       Date:  2016-08-03       Impact factor: 2.388

6.  A Cross-Sectional Study on Single-Day Use of Proton Pump Inhibitors in Tertiary Care Hospitals of South India.

Authors:  Zabiuddin Ahad M; Alekhya Lavu; Maria Ansari; Raviraj Acharya V; Rajesh Vilakkathala
Journal:  Hosp Pharm       Date:  2019-09-10

7.  Proton pump inhibitors and acute kidney injury: a nested case-control study.

Authors:  Donald G Klepser; Dean S Collier; Gary L Cochran
Journal:  BMC Nephrol       Date:  2013-07-16       Impact factor: 2.388

8.  Molecular pathways driving omeprazole nephrotoxicity.

Authors:  Miguel Fontecha-Barriuso; Diego Martín-Sanchez; Julio M Martinez-Moreno; Daniela Cardenas-Villacres; Susana Carrasco; Maria D Sanchez-Niño; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Redox Biol       Date:  2020-02-12       Impact factor: 11.799
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.